Human datasets showed that having higher levels of ACKR4 could be linked to a better disease prognosis in male patients with Burkitt lymphoma, a rare but aggressive form of B-cell lymphoma. The gene discussed is ACKR4; the disease is B-cell non-Hodgkin lymphoma.